Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis.
Ontology highlight
ABSTRACT: A biomarker specific for the diagnosis of amyotrophic lateral sclerosis must be sensitive across a spectrum of clinical heterogeneity. Neurofilament light chain levels in amyotrophic lateral sclerosis correlate with the rate of disability progression. Previous attempts to establish a diagnostic role for neurofilament light chain have been limited to comparison with healthy individuals or controls with alternative diagnoses unlikely to be confused with amyotrophic lateral sclerosis in real-world clinical practice. In a tertiary amyotrophic lateral sclerosis referral clinic, at first visit, serum was taken for neurofilament light chain measurement after prospectively recording the clinical diagnosis as 'amyotrophic lateral sclerosis', 'primary lateral sclerosis', 'alternative' or 'currently
SUBMITTER: Davies JC
PROVIDER: S-EPMC10244039 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA